Warburton Capital Management, LLC

Position in ABBV — AbbVie Inc.

CIK 2054795 TULSA, OK

Position in ABBV

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$225,721

+$21,223 QoQ

Shares Held

897

+0.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.65%

of 13F equity value

Holder Rank

#3,870

of 4,153 holders

Holding Since

Mar 2025

5 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Warburton Capital Management, LLC holds $1,474,189 across 5 Drug Manufacturers - General names. ABBV ranks #3 (15.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	472	$566,131
2	JNJ	Johnson & Johnson	1,006	$255,493
3	ABBV	AbbVie Inc. This page	897	$225,721
4	GILD	Gilead Sciences, Inc.	1,740	$219,831
5	MRK	Merck & Co., Inc.	1,611	$207,013

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$225,721	897	+0.2%	Shares	Sole	2026-08-03
2025-12-31	$204,498	895	-21.4%	Shares	Sole	2026-01-23
2025-09-30	$263,492	1,138	+3.5%	Shares	Sole	2025-10-10
2025-06-30	$203,996	1,099	+6.7%	Shares	Sole	2025-07-31
2025-03-31	$215,805	1,030	—	Shares	Sole	2025-05-09
No filing history on record for this holder in this stock.